2 ms·

Drug developers have a strong incentive to overstate what they spent developing a drug. Since they are the source of these numbers, I suspect they are inflated

Drug developers have a strong incentive to overstate what they spent developing a drug. Since they are the source of these numbers, I suspect they are inflated. If you were to take all of the drugs a company developed during some time period and add up their reported development costs the total would likely far exceed the companies total expenditure.

JBReefer 10y ago
That's a strong claim that you could probably support with data with little effort, but as it stands, it's conjecture. I do agree with your analysis, but it's a weak argument to incentive.